HRTX Heron Therapeuti
Company Analysis
Latest News
🟢 Heron Therapeutics is trading 5.9% up today with no identified company-specific catalyst
Heron Therapeutics is trading $0.34, up 5.90%, with no new company-specific announcement identified for August 12, 2026. - The August 10 earnings miss,...
🔴 Heron Therapeutics is trading 7.1% down today after Q2 revenue miss and full-year guidance withdrawal
Heron Therapeutics is trading 7.1% down now at $0.31 after its August 10, 2026 earnings release reported a revenue miss and the company withdrew full-year...
🔴 Heron Therapeutics is trading 23.82% down today after missing Q2 revenue and earnings expectations
Heron Therapeutics is trading 23.82% down now at $0.37 after its August 10, 2026, second-quarter results missed revenue and earnings expectations. - Revenue...
Heron Therapeutics Yanks Its 2026 Outlook and Hunts for a Lifeline — Is This a Turnaround Story or a Company Running Out of Road?
Shares of Heron Therapeutics cratered 13.5% to $0.42 Monday morning after the biotech missed second-quarter expectations and pulled its full-year guidance — a...
🔴 Heron Therapeutics is trading 13.53% down in pre-market after second-quarter 2026 revenue missed estimates
Heron Therapeutics is trading 13.53% down at $0.42 after second-quarter 2026 revenue missed expectations at $37.7 million versus the $42.19 million consensus...
🔴 Heron Therapeutics is trading 6.21% down in pre-market after Q2 revenue and earnings misses
Heron Therapeutics is trading 6.21% down in pre-market at $0.46 after its August 10, 2026 second-quarter report missed revenue and earnings expectations. -...
Heron Therapeutics misses second quarter 2026 estimates and withdraws full-year financial guidance
Heron Therapeutics reported second quarter 2026 results that missed analyst expectations on both the top and bottom lines. Management withdrew its previously...
Heron Therapeutics Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Consensus estimates for Heron Therapeutics anticipate a Q2 2026 loss of $0.02 per share on revenue of $42.19 million, with the stock currently trading near...
🟢 Heron Therapeutics is trading 10% up in pre-market with second-quarter results scheduled for August 10, 2026
Heron Therapeutics is trading 10.22% up at $0.55 in pre-market, with second-quarter results scheduled for August 10, 2026. - The company has not announced...
🟢 Heron Therapeutics is trading 6% up today amid biotech sector strength
Heron Therapeutics is trading 6% up at $0.54 in pre-market, as the stock benefits from ongoing biotech sector strength and a broader risk-on tone in U.S....
🟢 Heron Therapeutics is trading 5.3% up today amid broad market and biotech strength
Heron Therapeutics is trading 5.3% up at $0.54 amid a broad risk-on rally in U.S. equities and strength in biotech stocks. • The move appears driven by...
🟢 Heron Therapeutics is trading 5.2% up today amid broader market strength
Heron Therapeutics is trading at $0.52 (+5.17%) in after-hours trading, moving higher despite a lack of company-specific catalysts. • The price action appears...
🟢 Heron Therapeutics is trading 6.6% up today without a clear company catalyst
Heron Therapeutics is trading at $0.49 (up 6.6%) without a clear company catalyst, reversing several sessions of mild weakness. • No fresh company-specific...
🟢 Heron Therapeutics rises 6.1% — Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
With Biotech (XBI) up 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🟢 Heron Therapeutics is trading 6.2% up today in after-hours trading with no clear catalyst
Heron Therapeutics is trading 6.2% up at $0.50 in after-hours trading despite a lack of fresh company-specific news or fundamental catalysts. • The move...
🟢 Heron Therapeutics is trading 7.1% up today in after-hours trading with no clear catalyst
Heron Therapeutics is trading 7.1% up at $0.51 in after-hours trading, extending its gains from the regular session despite a lack of fresh news or specific...
🟢 Heron Therapeutics is trading 11.2% up
Heron Therapeutics is trading at $0.49, up 11.2% from a comparison close of $0.44 during regular trading. This is a price-action follow-up, so a separate...
🟢 Heron Therapeutics is trading 5.2% up today, extending a multi-day rebound
Heron Therapeutics is trading 5.2% up at $0.46, extending a multi-day rebound from last week’s lows. • The move appears to be a continuation of recent...
🔴 Heron Therapeuti is trading 5.51% down
HRTX is trading at $0.40, down 5.51%.
Heron Therapeutics Receives Nasdaq Non-Compliance Notice Over Minimum Bid Price
Heron Therapeutics (HRTX) announced it received a notice from Nasdaq for failing to maintain the minimum $1.00 per share bid price requirement for continued...